August 23, 2024 10:29 AM EDTUpdated 10:43 AM
News Briefing

Novo's in­no­va­tion hub ex­pands to Bay Area; SIGA's new Tpoxx or­der

Kyle LaHucik

Senior Reporter

No­vo Nordisk’s Bio In­no­va­tion Hub goes west: The Dan­ish phar­ma’s ear­ly-stage R&D unit is part­ner­ing with MBC Bi­o­Labs, an in­cu­ba­tor in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times